US FDA Regulatory Roundup: Ceba-Tek GMP Warning, Altaire Expands Recall
Executive Summary
GMP violations FDA warned Ceba-Tek about following an inspection in January and February include problems agency officials also noted in 2014 and 2015; Altaire Pharmaceuticals recalls of ophthalmic products due to lack of sterility assurance passes 500 lots, including 28 of Clear Eyes announced July 16.